3g-Nanotechnology based targeted drug delivery using the inner ear as a model target organ

Projektinformationen

NANOEAR

ID Finanzhilfevereinbarung: 26556

Projekt abgeschlossen

Startdatum 1 November 2006

Enddatum 31 Oktober 2011

Finanziert unter

• Nanotechnologies and nanosciences, knowledge-based multifunctional materials and new production processes and devices: thematic priority 3 under the 'Focusing and integrating community research' of the 'Integrating and strengthening the European Research Area' specific programme 2002-2006.

Gesamtkosten € 12 010 034,00

EU-Beitrag € 10 499 957,00

Koordiniert durch

TAMPEREEN YLIOPISTO
Finland

Sonstige Dokumente

• 3g-Nanotechnology based targeted drug delivery using the inner ear as a model target organ (NANOEAR) - Publishable Executive Summary